EVUSHELD Trademark

Trademark Overview

On Wednesday, December 23, 2020, a trademark application was filed for EVUSHELD with the United States Patent and Trademark Office. The USPTO has given the EVUSHELD trademark a serial number of 90407307. The federal status of this trademark filing is REGISTERED as of Tuesday, June 7, 2022. This trademark is owned by AstraZeneca UK Limited. The EVUSHELD trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparation and substance, namely, antibodies
evusheld

General Information

Serial Number90407307
Word MarkEVUSHELD
Filing DateWednesday, December 23, 2020
Status700 - REGISTERED
Status DateTuesday, June 7, 2022
Registration Number6755474
Registration DateTuesday, June 7, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 31, 2021

Trademark Statements

Goods and Servicespharmaceutical preparation and substance, namely, antibodies

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, March 10, 2021
Primary Code005
First Use Anywhere DateTuesday, December 14, 2021
First Use In Commerce DateTuesday, December 14, 2021

Trademark Owner History

Party NameAstraZeneca UK Limited
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressCambridge CB20AA
GB
Party NameAstraZeneca UK Limited
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressCambridge CB20AA
GB
Party NameAstraZeneca UK Limited
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressCambridge CB20AA
GB

Trademark Events

Event DateEvent Description
Tuesday, June 7, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, June 7, 2022REGISTERED-PRINCIPAL REGISTER
Friday, April 29, 2022ELECTRONIC RECORD REVIEW COMPLETE
Friday, April 1, 2022ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Tuesday, March 29, 2022NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Saturday, March 26, 2022ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, March 9, 2022STATEMENT OF USE PROCESSING COMPLETE
Monday, February 14, 2022USE AMENDMENT FILED
Wednesday, March 9, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, February 14, 2022TEAS STATEMENT OF USE RECEIVED
Tuesday, October 26, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 31, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 31, 2021PUBLISHED FOR OPPOSITION
Wednesday, August 11, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, July 29, 2021ELECTRONIC RECORD REVIEW COMPLETE
Friday, July 23, 2021ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Thursday, July 22, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, July 22, 2021TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Thursday, July 22, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, July 22, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, July 22, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, July 22, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, July 22, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, July 20, 2021ASSIGNED TO LIE
Monday, June 28, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, June 8, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, June 8, 2021NON-FINAL ACTION E-MAILED
Tuesday, June 8, 2021NON-FINAL ACTION WRITTEN
Monday, June 7, 2021ASSIGNED TO EXAMINER
Wednesday, March 10, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, December 26, 2020NEW APPLICATION ENTERED IN TRAM

Related Keywords

evusheld antibodies namely substance preparation pharmaceutical